MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ABCL — AbCellera Biologics Inc. Common Shares
NasdaqAbCellera Biologics Inc. Common Shares
$13.91
-0.68(-4.66%)
- O
- 14.59
- H
- 14.65
- L
- 13.79
- V
- 7.76M
⏱️ End-of-day dataAs of Oct 1, 2026
ABCL — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $77.06M | $12.85M | $83.16M | $92.44M | $15.93M | $15.63M |
| Other Short Term Investments | $42.77M | $40.53M | $41.25M | $46.06M | $44.60M | $46.93M |
| Accounts Receivable | $36.76M | $58.29M | $41.46M | $47.31M | $40.01M | $33.62M |
| Inventory | $7.86M | $6.34M | N/A | N/A | N/A | N/A |
| Restricted Cash | $25.00M | $25.00M | $25.00M | $25.00M | $25.00M | $25.00M |
| Other Current Assets | $11.28M | $9.67M | $15.11M | $10.70M | $8.10M | $8.63M |
| Total Current Assets | $66.46M | $72.82M | $69.51M | $74.21M | $76.50M | $75.14M |
| Properties | $23.81M | $23.91M | $23.51M | $23.03M | $15.65M | $15.09M |
| Land And Improvements | $53.41M | $53.41M | $53.41M | $53.41M | $53.41M | $53.41M |
| Accumulated Depreciation | $-63.53M | $-57.61M | $-52.63M | $-48.51M | $-43.98M | $-39.72M |
| Goodwill | $13.31M | $13.40M | $13.49M | $13.59M | $13.68M | $13.77M |
| Intangible Assets | $37.46M | $38.38M | $39.32M | $40.26M | $41.19M | $42.11M |
| Investments And Advances | $65.31M | $62.58M | $93.30M | $90.37M | $81.57M | $82.30M |
| Other Non Current Assets | $69.14M | $51.95M | $53.07M | $57.45M | $61.56M | $96.54M |
| Total Non Current Assets | $64.25M | $62.87M | $66.09M | $65.99M | $57.92M | $60.92M |
| Total Assets | $130.71M | $135.69M | $135.60M | $140.21M | $134.42M | $136.06M |
| Accounts Payable | $20.81M | $25.23M | $31.77M | $32.04M | $32.80M | $34.35M |
| Accrued Expenses | $3.93M | $10.76M | $7.23M | $4.96M | $3.19M | $8.38M |
| Short Term Debt | $5.87M | $5.82M | $5.17M | $4.90M | $4.64M | $4.62M |
| Deferred Revenue | $16.69M | $22.51M | $24.63M | $25.12M | $26.00M | $21.18M |
| Total Current Liabilities | $47.29M | $64.31M | $68.80M | $67.02M | $75.40M | $76.61M |
| Long Term Debt | $13.43M | $13.74M | $13.71M | $13.72M | $63.21M | $60.74M |
| Other Non Current Liabilities | $11.32M | $4.77M | $1.39M | $1.56M | $1.62M | $1.47M |
| Total Non Current Liabilities | $32.17M | $32.57M | $32.31M | $32.80M | $24.58M | $22.79M |
| Total Liabilities | $36.90M | $39.00M | $39.20M | $39.50M | $32.12M | $30.45M |
| Common Stock | $81.65M | $80.23M | $79.45M | $79.17M | $79.01M | $77.72M |
| Retained Earnings | $-72.65M | $-29.48M | $-20.54M | $36.58M | $71.31M | $11.69M |
| Other Shareholders Equity | $-2.42M | $-4.23M | $-2.70M | $-2.66M | $-7.00M | $-4.38M |
| Total Shareholders Equity | $93.81M | $96.69M | $96.40M | $100.71M | $102.30M | $105.61M |
| Additional Paid In Capital | $19.66M | $19.83M | $19.28M | $18.15M | $16.86M | $16.64M |
| Cash | N/A | $99.30M | N/A | N/A | N/A | N/A |
| Cash Equivalents | N/A | $29.30M | N/A | N/A | N/A | N/A |
| Deferred Liabilities | N/A | $9.12M | $9.74M | $10.05M | $10.05M | $10.05M |
| Leases | N/A | N/A | $13.84M | $13.58M | $12.82M | $12.29M |
| Provision For Risks And Charges | N/A | N/A | N/A | N/A | N/A | 0.00 |